Oh yeah...insulin copays are now limited to $35/month for nearly everyone thanks to the Inflation Reduction Act & American Rescue Plan

via U.S. News:

Managing diabetes will be a less expensive proposition for more Americans in 2024.

Sanofi has officially joined Novo Nordisk and Eli Lilly in lowering the cost of insulin to $35 a month for many patients. The three drug makers are also drastically lowering the list prices for their insulin products.

The price-cutting moves were first announced last spring, but some of them didn’t take effect until Jan. 1.

...Over 8 million Americans need insulin to survive, but up to a quarter of those patients haven't been able to afford the medication and have dangerously rationed doses, according to the ADA.

Now, thanks to the Inflation Reduction Act, Medicare enrollees pay no more than $35 a month for their insulin prescriptions.

"OK" you might be saying, "the IRA is responsible for Medicare enrollees being capped at $35/mo, but what about everyone else? Shouldn't the praise go to the drugmakers for cutting their insulin prices?"

Well, guess what?

...Still, these moves will save the companies hundreds of millions of dollars a year, experts told CNN. That's because the 2021 American Rescue Plan Act changed rebates that drug manufacturers pay annually to state Medicaid programs -- a change that kicked in on Jan. 1.